Advertisement

Evolution of Resistance to Erythromycin, Norfloxacin, and Tetracycline in Thermophylic Campylobacters

  • Claudio Piersimoni
  • Daniele Crotti
  • Domenico Nista
  • Stefano Bornigia
  • Giuseppina De Sio

Abstract

Thermophylic campylobacters are important enteric pathogens and have emerged as one of the leading causes of bacterial diarrhoea worldwide. Campylobacter enteritis is usually a mild to moderate self-limited disease and does not require antibiotic treatment except in severe cases when serious symptoms, relapses or a prolonged course of infection occur.

Keywords

Nalidixic Acid Resistance Rate Clinical Microbiology Tetracycline Resistance Agar Diffusion Method 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blaser M.J. (1990) In: G.L. Mandell, R.G. Douglas, and J.E. Bennet (ed), Principles and practise of infectious diseases. Churchill Livingstone Inc., New York, p. 1649–1658.Google Scholar
  2. 2.
    DuPont H.L. (1991) Eur. J. Clin. Microbiol. Infect. Dis., 10, 325–329.PubMedCrossRefGoogle Scholar
  3. 3.
    Endtz H.R, Mouton R.P., Van der Reyden T., Ruijs G.J., Biever M., Van Klingeren B. (1990) Lancet, 335, 787.PubMedCrossRefGoogle Scholar
  4. 4.
    Endtz H.R, Broeren M, Mouton R.R (1993) Eur. J. Clin. Microbiol. Infect. Dis., 12, 48–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Goossens H., Butzler J.R (1992) In: I. Nachamkin, M.J. Blaser, L.S. Tompkins (ed): Campylobacter jejuni: current status and future trend. American Society for Microbiology, Washington DC, p.93–109.Google Scholar
  6. 6.
    Hirschl A.M., Wolf D., Berger J., Rotter M.L. (1990) Intern. J. Med. Microbiol., 272, 443–447.Google Scholar
  7. 7.
    Lior H. (1984) J. Clin. Microbiol., 20, 636–640.PubMedGoogle Scholar
  8. 8.
    Penner J.L. (1988) Clin. Microbiol. Rev., 1, 157–172.PubMedGoogle Scholar
  9. 9.
    Rademaker C.M.A., Hoepelman I.M., Wolfhagen M.J.H.M., Beumer H., Rozemberg-Arska M., Verhoef J. (1989) Eur. J. Clin. Microbiol. Infect. Dis., 8, 690–694.PubMedCrossRefGoogle Scholar
  10. 10.
    Reina J., Jesus Ros M., Serra A. (1994) Antimicrob. Agents Chemother., 38, 2917–2920.PubMedCrossRefGoogle Scholar
  11. 11.
    Sanchez R., Fernandez-Baca V, Diaz D., Muñoz P., Rodriguez-Crèixems M., Bouza E. (1994) Antimicrob. Agents Chemother., 38, 1879–1882.PubMedCrossRefGoogle Scholar
  12. 12.
    Taylor D.E., Courvalin P. (1983) Antimicrob. Agents Chemother., 24, 930–935.PubMedCrossRefGoogle Scholar
  13. 13.
    Wang Y, Huang W.M., Taylor D.E. (1993) Antimicrob. Agents Chemother., 37, 457–463.PubMedCrossRefGoogle Scholar
  14. 14.
    Williams D.M., Schorling J.B., Barrett L.J., Dudley S.M., Orgel J., Koch W.C., Shields D.H., Thomson S.M., Lohr J.A., Guerrant R.L. (1989) Antimicrob. Agents Chemother., 33, 248–250.PubMedCrossRefGoogle Scholar
  15. 15.
    Wistrom J., Jertborn M., Hedstrom S.A., Alestig K., Englund G., Jellheden B. (1989) J. Antimicrob. Chemother. 23, 905–913.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Claudio Piersimoni
    • 1
  • Daniele Crotti
    • 2
  • Domenico Nista
    • 1
  • Stefano Bornigia
    • 1
  • Giuseppina De Sio
    • 1
  1. 1.Department of Clinical Microbiology“Umberto I°-Torrette” HospitalAnconaItaly
  2. 2.Department of Clinical Microbiology“R. Silvestrini” HospitalSan Sisto-PerugiaItaly

Personalised recommendations